Skip to content
Stock screener

SOLV Solventum Corp stock chart & analysis

Conviction 52HealthcareScan · Fri, Nov 6, 2026
Bullish engulfing

Solventum Corp (SOLV) closed at $90.38 (+3.67%) on Nov 6, 2026. Its latest daily candle is a bullish engulfing. Price is above its 50-day and above its 200-day moving average. RSI(14) 59, RS Rating 88, -4.0% from its 52-week high, +14.0% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.

SOLV$90.38+3.67%
ResistanceSupportVol 14Congress buyCongress sell
Loading chart…
Solventum CorpSurgical & Medical Instruments & Apparatuswww.solventum.com ↗
Price90.38
Change+3.67%
Gap-0.72%
Rel volume2.68×
Avg volume1.31M
Avg $ vol112.97M
SMA 2085.77
SMA 5087.72
SMA 20078.55
Price vs 50+2.99%
Price vs 200+15.01%
MA stackbullish
50/200 cross—
Supertrendup · 81.06
RSI (14)59
MACD hist0.63
MACD crossbull · 2d
Stoch %K / %D78 / 77
ADX (14)20
+DI / −DI25 / 21
RSI divergence—
MACD divergence—
ATR %3.37%
ADR %3.21%
52w high94.16
52w low62.38
From 52w high-4.05%
Above 52w low+44.83%
New 52w highNo
SqueezeOff
Bollinger width10.29%
%B1.02
Donchian pos78.31%
Donchian high93.00
Donchian low80.76
AVWAP (52w high)87.54
vs AVWAP high+3.21%
AVWAP (52w low)79.87
vs AVWAP low+13.12%
OBV trendUp
Chaikin MF (20)-0.04
Today vs 20d2.68×
Avg vol (14d)1.4M
Avg vol (20d)1.31M
Avg $ vol (20d)112.97M
Market cap15.34B
RS Rating88 / 99
RS 3m (vs SPY)+10.89%
RS 6m (vs SPY)+23.42%
RS line new highYes
Trend template8/8
Technical rank88.4
1 week+11.08%
1 month+4.55%
3 months+6.03%
6 months+23.12%
1 year+33.47%
YTD+14.01%
P/E9.86
P/B3.19
P/S1.84
P/FCF-1533.51
EPS8.88
Div yield—
ROE32.38%
ROA10.98%
Debt/Eq1.05
Current1.03
EV/EBITDA7.47
Gross margin53.47%
Net margin18.69%
Rev growth0.86%
EPS growth224.84%
Price target101.63
Target upside12.49%
Analyst ratingBuy
Institutional85.20%
Ent. value19.95B
Revenue1.95B
Net income-12M
Gross profit1.06B
Free cash flow-10M
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNYSE
Shares out173.17M
Employees20K
ListedTue, Mar 26, 2024
Free float147.57M
Float %85.1%
Short interest—
Days to cover—
Short volume35.8%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$1.45 vs $1.35
Last surprise+7.4% beat
Setup gradeD
Conviction52 / 100
Pattern quality—
Tech rank88.4 / 100
Group rank23 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing

Financials as of Wed, Sep 30, 2026 · quarterly.

SOLV technical analysis

Trend

SOLV is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 3.0% above the 50-day ($87.72) and 15.0% above the 200-day ($78.55). ADX(14) at 20 points to a weak trend — more range than direction. It meets 8 of 8 trend-template criteria.

Momentum

RSI(14) is 59, in the bullish half of its range. MACD crossed above its signal line 2 sessions ago. Its RS Rating of 88 puts its weighted 12-month performance ahead of about 88% of the US market, and its RS line is at a new high.

Volume and volatility

Volume on the latest session ran 2.7× its 20-day average. It trades about $113.0M a day on average. ATR(14) is $3.05, 3.4% of price — its typical daily range. On-balance volume is trending up.

Key levels

The 52-week range is $62.38 to $94.16; price is 4.0% below the high and 44.8% above the low. The VWAP anchored at the 52-week high is $87.54, below price.

Performance

SOLV returned +11.1% (1 week), +4.5% (1 month), +6.0% (3 months), +23.1% (6 months), +33.5% (1 year), +14.0% (year to date).

About Solventum Corp

Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.

Surgical & Medical Instruments & Apparatus · Listed 2024 · 20,000 employees

Congress activity

Disclosed STOCK Act trades in SOLV · 7 recent

All disclosures →
MemberSideAmount
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$1K–$15K
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
James French Hill
James French Hill
house · AR · traded 2025-12-31
Sell$15K–$50K
Ron L Wyden
Ron L Wyden
senate · D · OR · traded 2025-02-06
Sell$1K–$15K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-01-15
Sell$1K–$15K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Buy$1K–$15K
Gary C Peters
Gary C Peters
senate · D · MI · traded 2024-05-14
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in SOLV

InsiderSideShares
Zieselman Neil Craig
SVP, Controller & CAO · Restricted Stock Units · 2026-08-17
Grant6.91K
Wilson Darryl L.
Director · Restricted Stock Units · 2026-05-15
Grant3.3K
DeVore Susan D.
Director · Restricted Stock Units · 2026-05-15
Grant3.3K
Harris Bernard A Jr
Director · Restricted Stock Units · 2026-05-15
Grant3.3K
WEILAND JOHN H
Director · Restricted Stock Units · 2026-05-15
Grant3.3K
Edwards Shirley Ann
Director · Restricted Stock Units · 2026-05-15
Grant3.3K
COX CARRIE SMITH
Director · Restricted Stock Units · 2026-05-15
Grant4.85K
EISENBERG GLENN A
Director · Restricted Stock Units · 2026-05-15
Grant3.3K
Mily Elizabeth
Director · Restricted Stock Units · 2026-05-15
Grant3.3K
ALBAN CARLOS
Director · Restricted Stock Units · 2026-05-15
Grant3.3K

SEC filings

EDGAR filings in SOLV · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.